跳至主要内容
临床试验/CTRI/2020/09/027989
CTRI/2020/09/027989已完成未知

Comparative study of the efficacy and safety of EUS guided liver biopsy versus percutaneous liver biopsy: A multi-center randomized controlled trial

Jayanta Samanta0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.All patients referred for liver biopsy for any indication.
  • 2.Informed consent obtained from the patient/parent
  • 3.= 12 years old
  • 4.Ability to undergo conscious sedation for EUS procedure

排除标准

  • 1.Age <12 years old
  • 2.Unable to obtain informed consent from the patient/parent
  • 3.Medically unfit for sedation
  • 4.Pregnant patients
  • 5.Presence of a mass lesion in the liver requiring biopsy visualized on cross-sectional imaging
  • 6.Irreversible coagulopathy as determined by platelet count < 50,000 mm3 or International Normalized Ratio (INR) > 1.5
  • 7.Unable to stop anticoagulation or anti-platelet therapy for 5 days prior to the procedure
  • 8.Hemophilia
  • 9.Presence of an alternative etiology for elevated liver tests seen during the liver biopsy, e.g. biliary obstruction during EUS examination
  • 10.Suspected or proven malignant liver disease.
  • 11.severe cardiovascular and pulmonary diseases

研究者

相似试验